Vaccination protects overweight, obese against severe COVID-19
Jul 01, 2022
Protection against severe COVID-19 was similar for those who were overweight or obese versus those at a healthy weight; lower protection was seen for those who were underweight.
Pfizer has two updated booster shots to help fight omicron
Jun 27, 2022
The company said Saturday that it was confident that its new booster candidates are better than their predecessor.
Veterans report low rates of adverse events with mRNA vaccines
Jun 16, 2022
Rates were slightly higher at 42 days for those receiving the Pfizer versus Moderna vaccine.
COVID-19 vaccines cut mortality with heart failure
Jun 16, 2022
Those who are partially vaccinated and unvaccinated face the same increased risk, whereas boosted and fully vaccinated adults fare best.
Vaccine effectiveness against SARS-CoV-2 infection wanes over time
Jun 14, 2022
However, for all ages, vaccine effectiveness against severe COVID-19 was high overall, at 90% five months or longer after two doses.
Social isolation may be independent risk factor for dementia
Jun 10, 2022
Lower gray matter volumes in temporal, frontal, other regions were seen in socially isolated individuals.
Food allergy tied to lower risk for SARS-CoV-2 infection
Jun 09, 2022
Asthma does not raise the risk for infection or household transmission.
Most neurologic symptoms persist for COVID-19 long haulers
Jun 02, 2022
SARS-CoV-2 vaccination appears to have no positive or negative impact on cognitive function or fatigue.
Vaccination cuts risk of severe COVID-19 in patients on dialysis
Jun 01, 2022
There was a reduction in risk of admission and deaths with prior two-dose vaccination versus no vaccination.
Vaccination offers partial protection for postacute phase of COVID-19
May 31, 2022
Individuals with breakthrough infection have an increased risk for death and postacute sequelae compared with contemporary controls.